Skip to Content

MainStay Epoch International Choice Inv ICELX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 40.98  /  +0.79 %
  • Total Assets 218.7 Mil
  • Adj. Expense Ratio
    1.510%
  • Expense Ratio 1.510%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 1.12%
  • Turnover 34%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:05 PM GMT+0

Morningstar’s Analysis ICELX

Will ICELX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay Epoch International Choice Inv's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ICELX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 40.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AstraZeneca PLC ADR

5.42 11.7 Mil
Healthcare

Lloyds Banking Group PLC

4.50 9.7 Mil
Financial Services

Sony Group Corp

4.28 9.2 Mil
Technology

Novo Nordisk A/S Class B

4.14 8.9 Mil
Healthcare

NN Group NV

4.11 8.8 Mil
Financial Services

Keyence Corp

4.06 8.7 Mil
Technology

Deutsche Telekom AG

3.47 7.5 Mil
Communication Services

Linde PLC

3.44 7.4 Mil
Basic Materials

Asahi Group Holdings Ltd

3.40 7.3 Mil
Consumer Defensive

TotalEnergies SE

3.39 7.3 Mil
Energy